nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing Ethical and Procedural Principles for Unrelated Allogeneic Hematopoietic Progenitor Cell Donation in a Changing Medical Environment
|
van Walraven, Suzanna M. |
|
2018 |
24 |
5 |
p. 887-894 |
artikel |
2 |
Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Cappell, Kathryn |
|
2018 |
24 |
5 |
p. 1035-1040 |
artikel |
3 |
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation
|
Tamari, Roni |
|
2018 |
24 |
5 |
p. 1079-1087 |
artikel |
4 |
ASBMT Notes
|
|
|
2018 |
24 |
5 |
p. 1103-1105 |
artikel |
5 |
Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis
|
Shouval, Roni |
|
2018 |
24 |
5 |
p. 937-944 |
artikel |
6 |
Bad Blood or Sick Patient?
|
Sedhom, Ramy |
|
2018 |
24 |
5 |
p. 884-886 |
artikel |
7 |
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
|
Barba, Pere |
|
2018 |
24 |
5 |
p. 964-972 |
artikel |
8 |
Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation
|
Bhella, Sita |
|
2018 |
24 |
5 |
p. 909-913 |
artikel |
9 |
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most
|
Shaw, Bronwen E. |
|
2018 |
24 |
5 |
p. 1049-1056 |
artikel |
10 |
Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation
|
Horváth, Orsolya |
|
2018 |
24 |
5 |
p. 989-996 |
artikel |
11 |
Editorial Board
|
|
|
2018 |
24 |
5 |
p. A8 |
artikel |
12 |
Evaluation of Chimerism Dynamics after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Nonmalignant Diseases
|
Faraci, Maura |
|
2018 |
24 |
5 |
p. 1088-1093 |
artikel |
13 |
Experiences and Decision Making in Hematopoietic Stem Cell Transplant in Sickle Cell Disease: Patients' and Caregivers' Perspectives
|
Khemani, Kirshma |
|
2018 |
24 |
5 |
p. 1041-1048 |
artikel |
14 |
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non–First-Degree Related Donors
|
Elmariah, Hany |
|
2018 |
24 |
5 |
p. 1099-1102 |
artikel |
15 |
Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma
|
Illhardt, Toni |
|
2018 |
24 |
5 |
p. 1005-1012 |
artikel |
16 |
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
|
Sahebi, Firoozeh |
|
2018 |
24 |
5 |
p. 930-936 |
artikel |
17 |
Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant
|
Hwang, Jessica P. |
|
2018 |
24 |
5 |
p. 1094-1098 |
artikel |
18 |
Masthead (Purpose and Scope)
|
|
|
2018 |
24 |
5 |
p. A6 |
artikel |
19 |
Officers and Directors of ASBMT
|
|
|
2018 |
24 |
5 |
p. A9 |
artikel |
20 |
Perceived Workforce Challenges among Clinical Social Workers in Hematopoietic Cell Transplantation Programs
|
Stickney Ferguson, Stacy |
|
2018 |
24 |
5 |
p. 1063-1068 |
artikel |
21 |
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
|
Hosoba, Sakura |
|
2018 |
24 |
5 |
p. 973-982 |
artikel |
22 |
Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)
|
Jung, Sung-Hoon |
|
2018 |
24 |
5 |
p. 923-929 |
artikel |
23 |
Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation
|
Bejanyan, Nelli |
|
2018 |
24 |
5 |
p. 945-955 |
artikel |
24 |
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016
|
Al Malki, Monzr M. |
|
2018 |
24 |
5 |
p. 895-908 |
artikel |
25 |
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation
|
Patel, Sagar S. |
|
2018 |
24 |
5 |
p. 1029-1034 |
artikel |
26 |
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults
|
Tsai, Stephanie B. |
|
2018 |
24 |
5 |
p. 997-1004 |
artikel |
27 |
Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors
|
Duléry, Rémy |
|
2018 |
24 |
5 |
p. 1013-1021 |
artikel |
28 |
Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
|
Sullivan, Keith M. |
|
2018 |
24 |
5 |
p. 883-884 |
artikel |
29 |
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation
|
Kasamon, Yvette L. |
|
2018 |
24 |
5 |
p. 1022-1028 |
artikel |
30 |
Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation
|
Epperla, Narendranath |
|
2018 |
24 |
5 |
p. 983-988 |
artikel |
31 |
Table of Contents
|
|
|
2018 |
24 |
5 |
p. A15-A31 |
artikel |
32 |
The Hematopoietic Cell Transplant Pharmacist: Roles, Responsibilities, and Recommendations from the ASBMT Pharmacy Special Interest Group
|
Clemmons, Amber B. |
|
2018 |
24 |
5 |
p. 914-922 |
artikel |
33 |
Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia
|
Deeg, H. Joachim |
|
2018 |
24 |
5 |
p. 956-963 |
artikel |
34 |
Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies
|
Kliman, David |
|
2018 |
24 |
5 |
p. 1069-1078 |
artikel |
35 |
Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation
|
Davis, Eric |
|
2018 |
24 |
5 |
p. 1057-1062 |
artikel |